Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of 2 years chemotherapy

Tubercle. 1972 Sep;53(3):153-65. doi: 10.1016/0041-3879(72)90012-8.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Antitubercular Agents / therapeutic use*
  • Bilirubin / blood
  • Capreomycin / adverse effects
  • Capreomycin / therapeutic use
  • Clinical Trials as Topic
  • Ethambutol / adverse effects
  • Ethambutol / therapeutic use*
  • Female
  • Humans
  • Hypokalemia / chemically induced
  • Kidney Function Tests
  • Liver Function Tests
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis / isolation & purification
  • Potassium / blood
  • Rifampin / therapeutic use*
  • Sputum / microbiology
  • Tuberculosis, Pulmonary / drug therapy*
  • Vision Disorders / chemically induced
  • Visual Acuity

Substances

  • Antitubercular Agents
  • Capreomycin
  • Ethambutol
  • Alanine Transaminase
  • Bilirubin
  • Potassium
  • Rifampin